1. Home
  2. BWA vs CYTK Comparison

BWA vs CYTK Comparison

Compare BWA & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWA
  • CYTK
  • Stock Information
  • Founded
  • BWA 1987
  • CYTK 1997
  • Country
  • BWA United States
  • CYTK United States
  • Employees
  • BWA N/A
  • CYTK N/A
  • Industry
  • BWA Auto Parts:O.E.M.
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • BWA Consumer Discretionary
  • CYTK Health Care
  • Exchange
  • BWA Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • BWA 6.3B
  • CYTK 5.6B
  • IPO Year
  • BWA 1993
  • CYTK 2004
  • Fundamental
  • Price
  • BWA $32.78
  • CYTK $32.43
  • Analyst Decision
  • BWA Buy
  • CYTK Buy
  • Analyst Count
  • BWA 14
  • CYTK 14
  • Target Price
  • BWA $38.08
  • CYTK $70.92
  • AVG Volume (30 Days)
  • BWA 2.9M
  • CYTK 1.4M
  • Earning Date
  • BWA 07-30-2025
  • CYTK 08-07-2025
  • Dividend Yield
  • BWA 1.34%
  • CYTK N/A
  • EPS Growth
  • BWA N/A
  • CYTK N/A
  • EPS
  • BWA 1.30
  • CYTK N/A
  • Revenue
  • BWA $14,006,000,000.00
  • CYTK $19,218,000.00
  • Revenue This Year
  • BWA N/A
  • CYTK $18.02
  • Revenue Next Year
  • BWA $2.97
  • CYTK $737.32
  • P/E Ratio
  • BWA $23.43
  • CYTK N/A
  • Revenue Growth
  • BWA N/A
  • CYTK 412.21
  • 52 Week Low
  • BWA $24.40
  • CYTK $29.31
  • 52 Week High
  • BWA $37.29
  • CYTK $61.38
  • Technical
  • Relative Strength Index (RSI)
  • BWA 52.76
  • CYTK 46.32
  • Support Level
  • BWA $32.81
  • CYTK $32.02
  • Resistance Level
  • BWA $33.47
  • CYTK $34.72
  • Average True Range (ATR)
  • BWA 0.66
  • CYTK 1.30
  • MACD
  • BWA -0.15
  • CYTK 0.26
  • Stochastic Oscillator
  • BWA 38.31
  • CYTK 45.08

About BWA BorgWarner Inc.

BorgWarner is a tier one supplier of turbo and thermal management technologies, drivetrain systems, powerdrive systems, and battery and charging systems mostly to automotive original equipment manufacturers. Its products aim to move a vehicle with as few electrons as possible, resulting in cleaner, cost-optimized, and more-efficient vehicles. Foundational products, the combustion vehicle business, contributes more than 80% to group revenue while BorgWarner transitions to becoming an electric vehicle-centric parts supplier (e-business). In 2023, 25% of the company's revenue was sourced from Volkswagen and Ford. Revenue is well diversified geographically, with approximately a third each generated in North America, Europe, and Asia.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: